Vital Signsby BridgeheadAll voices

01  Voice · Academic · Respiratory (asthma/COPD)

Michalis Papadakis: no photograph is held, so the academic plate is shown instead.
Academic

Michalis Papadakis

CEO and Co-Founder of Brainomix

Press citations per month · linked articles
1
0
Oct 2026Nov 2026to date
1

press citation on 1 topic since 15 Oct 2026 · last quoted 15 Oct 2026

02  Quoted on · 1 of 29 topics

Open the topic

Michalis Papadakis: key facts

Kind of voice
Academic
Role
CEO and Co-Founder of Brainomix
Tracked press citations
1
Most recently quoted
15 Oct 2026

04  On the record · press

What Michalis Papadakis has said

By outlet · linked articles
  • scientistlive.com1

Where Michalis Papadakis has been quoted

  1. 01Brainomix partnership brings patient perspectives to AI-powered pulmonary fibrosis care - Scientist Livescientistlive.com · 15 Oct 2026

Verbatim

“Patients are at the heart of everything we are trying to achieve with e-Lung, while our technology can provide new imaging tools for lung disease, we need to understand how those tools inform clinical understanding and how that information is communicated to and understood by the people living with the disease.”
CEO and Co-Founder of Brainomix · Respiratory (asthma/COPD) · scientistlive.com · 15 Oct 2026 · Read the article

Related media coverage

Recent UK press coverage of their topics, not necessarily citing them directly.

Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 12 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.